A 52-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Ustekinumab in Patients With Moderate-to-Severe Plaque Psoriasis

The main purpose of this study is to evaluate the efficacy of the study drug ixekizumab compared to ustekinumab in participants with moderate-to-severe-plaque psoriasis.

本研究的主要目的为评估研究药物依奇珠单抗（ixekizumab）对比乌司奴单抗（ustekinumab）在中重度斑块型银屑病受试者中的疗效。